Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 12/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.33 |
| ▸ | CTSB | P07858 | 1/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14958646 | 0.87 | FOLH1 (0.42) | FOLH1TAS1R3TAS1R1 | |
| SCHEMBL15180217 | 0.83 | EPHX1 (0.37) | ACHETYRCTSLCTSBCTSS | |
| SCHEMBL30174611 | 0.70 | BIRC2 (0.54) | ACHEFOLH1TAS1R3TAS1R1 | |
| SCHEMBL14373742 | 0.69 | ALDH1A1 (0.50) | ACHE | |
| SCHEMBL11675839 | 0.69 | ALDH1A1 (0.50) | ACHE | |
| SCHEMBL27864476 | 0.69 | ALDH1A1 (0.50) | ACHE | |
| SCHEMBL11675841 | 0.69 | ALDH1A1 (0.50) | ACHE | |
| SCHEMBL13960047 | 0.69 | ALDH1A1 (0.50) | FOLH1TAS1R3TAS1R1 | |
| SCHEMBL7279383 | 0.68 | FOLH1 (0.47) | FOLH1TAS1R3TAS1R1 | |
| SCHEMBL7279380 | 0.68 | FOLH1 (0.47) | FOLH1TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080299174-A1 | Bis-(Alpha-Amino)-Diol-Diester-Containing Poly (Ester Amide) and Poly (Ester Urethane) Compositions and Methods of Use | MEDIVAS, LLC | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299174-A1 | Bis-(Alpha-Amino)-Diol-Diester-Containing Poly (Ester Amide) and Poly (Ester Urethane) Compositions and Methods of Use | APEH, DAO, DNPEP | ACHE 489/4885TYR 1611/4885CTSL 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.